SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
sars-cov-2 infection
Journals
2
1
american journal of kidney diseases : the official journal of the national kidney foundation
2
the lancet neurology
Research Groups
0
No Research Group Connected
Bibliographies
34
1
Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China.
2
Neurological associations of COVID-19.
3
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
4
Response to: Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".
5
Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection.
6
The evidence of SARS-CoV-2 infection on ocular surface.
7
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
8
SARS-CoV-2 infection control measures for the anesthesiology department: experience from the Sichuan Provincial People's Hospital, China.
9
Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection (Nature Communications, (2020), 11, 1, (2251), 10.1038/s41467-020-16256-y)
10
A human monoclonal antibody blocking SARS-CoV-2 infection
11
SARS-CoV-2 infection and air pollutants: Correlation or causation?
12
Recommendation about the perioperative prevention of infection to healthcare workers and the anesthesia management of children with SARS-CoV-2 infection
13
Repositioning PARP inhibitors for SARS-CoV-2 infection (COVID-19); a new multi-pronged therapy for ARDS?
14
Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
15
[Epidemiology of SARS-CoV-2 infection and COVID-19].
16
Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
17
Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection.
18
Quantitative assessment of the risk of airborne transmission of SARS-CoV-2 infection: Prospective and retrospective applications
19
Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection.
20
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
21
Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors
22
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
23
Chronic asymptomatic SARS-CoV-2 infection in the immunocompromised patient: new challenges and urgent needs
24
Susceptibility to SARS-CoV-2 infection in patients undergoing chemotherapy and radiation therapy
25
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents
26
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
27
Quantitative assessment of the risk of airborne transmission of SARS-CoV-2 infection: prospective and retrospective applications
28
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020
29
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020
30
Characteristics and Factors Associated with SARS-CoV-2 Infections in Individuals That Attended Referral Hospitals from Southern Region of Bahia State, Brazil: A Surveillance Network Retrospective Study
31
Genital Dysbiosis and Different Systemic Immune Responses Based on the Trimester of Pregnancy in SARS-CoV-2 Infection.
32
Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.
33
In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection
34
In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection